Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases

Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases

Neurodegenerative diseases (NDs), such as Alzheimer’s (AD), Parkinson’s (PD), and amyotrophic lateral sclerosis (ALS), share common pathological mechanisms, including metabolism alterations. However, their specific neuronal cell types affected and molecular biomarkers suggest that there are both com...

Full description

Bibliographic Details
Main Authors: Débora Lanznaster, Giulia Dingeo, Rayhanatou Altine Samey, Patrick Emond, Hélène Blasco
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Metabolites
Subjects:
metabolomics
neurodegenerative diseases
glutamate
therapy
Online Access:https://www.mdpi.com/2218-1989/12/9/864

Similar Items

Similar Items